Long-term follow-up and safety of vandetanib for advanced medullary thyroid cancer
Helton Estrela Ramos, Fábio Hecht, A. Berdelou, Isabelle Borget, Sophie Leboulleux, Éric Baudin, Martin Schlumberger
Topics & Concepts
VandetanibMedicineMedullary thyroid cancerInternal medicineGastroenterologyCancerThyroid cancerUrologyOncologySurgeryHepatocellular carcinomaSorafenibThyroid Cancer Diagnosis and TreatmentThyroid Disorders and TreatmentsThyroid and Parathyroid Surgery